Earnings Data
Report Date
Nov 16, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.11Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
DE:IQT0 Q2 2026 Earnings Report
DE:IQT0 Upcoming Earnings
Inhibikase Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
DE:IQT0 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:IQT0 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 11, 2026 | €2.50 | €2.50 | 0.00% |
May 12, 2026 | €2.50 | €2.50 | 0.00% |
Mar 26, 2026 | €2.50 | €2.50 | 0.00% |
Nov 14, 2025 | €2.50 | €2.50 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Inhibikase Therapeutics (DE:IQT0) report earnings?
Inhibikase Therapeutics (DE:IQT0) is schdueled to report earning on Nov 16, 2026, After Close (Confirmed).
What is Inhibikase Therapeutics (DE:IQT0) earnings time?
Inhibikase Therapeutics (DE:IQT0) earnings time is at Nov 16, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Inhibikase Therapeutics stock?
The P/E ratio of Inhibikase Therapeutics is N/A.
What is DE:IQT0 EPS forecast?
DE:IQT0 EPS forecast for the fiscal quarter 2026 (Q3) is -0.1.